Inventor · disambiguated record
T. G. Murali Dhar
Also filed as: DHAR T G MURALI
70 granted patents·3 pending applications·542 citations·filing 1993–2023
99Inventor score
Top patents by PatentIndex Score
73 records- 0195US6620815B1Oxazolidinones and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Sep 16, 2003·50 cites·40 claims
- 0290US10435369B2Tricyclic sulfones as ROR gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 8, 2019·6 cites·6 claims
- 0390US9815859B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 14, 2017·11 cites·15 claims
- 0490US6710064B2Hydantoin compounds useful as anti-inflammatory agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 23, 2004·27 cites·19 claims
- 0590US6399773B1Compounds derived from an amine nucleus that are inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jun 4, 2002·105 cites·26 claims
- 0688US9115054B2Tetrahydronaphthalenyl compounds useful as sipi agonistsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 25, 2015·13 cites·20 claims
- 0786US10273259B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 30, 2019·4 cites·1 claims
- 0886US7060720B2Inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jun 13, 2006·20 cites·12 claims
- 0986US6624184B1Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disordersBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Sep 23, 2003·57 cites·19 claims
- 1085US7205324B2Inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 17, 2007·20 cites·12 claims
- 1185US7053111B2Inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 30, 2006·20 cites·11 claims
- 1284US7375237B2Pyrrolizine compounds useful as anti-inflammatory agentsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 20, 2008·4 cites·5 claims
- 1384US6977267B2Spiro-hydantoin compounds useful as anti-inflammatory agentsCEREP SA·Filed 2002·Granted Dec 20, 2005·18 cites·24 claims
- 1482US10166249B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·2 cites·7 claims
- 1582US9458171B2Pyrrolidinyl sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 4, 2016·4 cites·14 claims
- 1682US7381737B2Crystalline forms and process for preparing spiro-hydantoin compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 3, 2008·8 cites·60 claims
- 1782US6596747B2Compounds derived from an amine nucleus and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 22, 2003·20 cites·13 claims
- 1881US9522888B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 20, 2016·2 cites·12 claims
- 1981US7186727B2Pyridyl-substituted spiro-hydantoin compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Mar 6, 2007·5 cites·8 claims
- 2080US8034940B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 11, 2011·4 cites·11 claims
- 2180US6919335B2Heterocycles that are inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 19, 2005·16 cites·22 claims
- 2278US11701373B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 18, 2023·0 cites·5 claims
- 2377US7943617B2Heterobicyclic compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 17, 2011·2 cites·4 claims
- 2477US7935696B2Heterocyclic amide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 3, 2011·2 cites·9 claims
- 2575US11058696B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 13, 2021·0 cites·4 claims
- 2675US10035790B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jul 31, 2018·3 cites·13 claims
- 2775US10023576B2Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 17, 2018·2 cites·10 claims
- 2875US7078420B2Spiro-hydantoin compounds useful as anti-inflammatory agentsCEREP SA·Filed 2004·Granted Jul 18, 2006·7 cites·22 claims
- 2974US6727257B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 2000·Granted Apr 27, 2004·7 cites·42 claims
- 3073US6777426B2Imidazole and imidazoline derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Aug 17, 2004·4 cites·12 claims
- 3172US10709719B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 14, 2020·0 cites·10 claims
- 3272US5942517A5-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1997·Granted Aug 24, 1999·28 cites·29 claims
- 3370US9216972B2Tricyclic heterocyclic compoundsDHAR T G MURALI·Filed 2010·Granted Dec 22, 2015·2 cites·16 claims
- 3470US8067447B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofSHEPPECK JAMES E·Filed 2007·Granted Nov 29, 2011·2 cites·12 claims
- 3570US7199125B2Spiro-cyclic compounds useful as anti-inflammatory agentsCEREP SA·Filed 2004·Granted Apr 3, 2007·5 cites·18 claims
- 3670US7008958B22-substituted 5-oxazolyl indole compounds useful as IMPDH inhibitors and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 7, 2006·4 cites·13 claims
- 3770US6268369B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 31, 2001·28 cites·21 claims
- 3868US10865191B2Heterocyclic compounds useful as modulators of TNF alphaBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 15, 2020·1 cites·4 claims
- 3968US10711020B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 14, 2020·0 cites·1 claims
- 4067US6420403B1Inhibitors of IMPDH enzymeFiled 1999·Granted Jul 16, 2002·11 cites·23 claims
- 4166US8013004B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Sep 6, 2011·0 cites·6 claims
- 4266US2025376474A1Ret-ldd protein degradersBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4363US9771320B2Carbocyclic sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 26, 2017·1 cites·15 claims
- 4461US6673825B2Urazole compounds useful as anti-inflammatory agentsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jan 6, 2004·1 cites·20 claims
- 4559US9487481B2Bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 8, 2016·0 cites·3 claims
- 4657US5866579AImidazole and imidazoline derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1997·Granted Feb 2, 1999·9 cites·8 claims
- 4757US2005004153A1Spiro-hydantoin compounds useful as anti-inflammatory agentsFiled 2004·Application pending·0 cites
- 4856US11078186B2ROR γ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 3, 2021·0 cites·4 claims
- 4956US7642273B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 5, 2010·0 cites·4 claims
- 5056US2004259897A1Spiro-hydantoin compounds useful as anti-inflammatory agentsFiled 2004·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when T. G. Murali Dhar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →